Part 4 Amendment to Part 3 (Authorisation for Clinical Trials and Ethics Committee Opinion)
Part 5 Amendment to Part 4 (Good Clinical Practice and the Conduct of Clinical Trials)
Part 7 Amendment to Part 6 (Manufacture and Importation of Investigational Medicinal Products)
Part 8 Insertion of new Part 6A (Non-Investigational Medicinal and Non-Medicinal Products)
Part 9 Substitution of Part 7 (Labelling of Investigational Medicinal Products)
Part 10 Amendment to Part 8 (Enforcement and Related Provisions)